BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Start Up

Collaborations

Dyax Corp.  Antibody phage display





 Company News
Merrimack Pharmaceuticals Inc. (MACK) Presents Additional Phase 2 Biomarker Data Further Strengthening The Finding That MM-121 Increases Progression Free Survival In Patients With Biomarker Positive Metastatic Breast Cancer 9/30/2014 7:40:45 AM
Baxter International, Inc. (BAX)'s Deal With Merrimack Pharmaceuticals Inc. (MACK) All Upside: Analyst 9/26/2014 12:04:50 PM
Baxter International, Inc. (BAX) Inks A $970 Million Pact For Merrimack Pharmaceuticals Inc. (MACK)'s Lead Cancer Drug MM-398 9/24/2014 6:02:00 AM
Merrimack Pharmaceuticals Inc. (MACK)To Present Clinical And Biomarker Data On Novel Antibody Therapeutics At The ESMO 2014 Congress 9/19/2014 7:18:06 AM
Merrimack Pharmaceuticals Inc. (MACK) Reports Second Quarter 2014 Financial Results 8/11/2014 7:41:11 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Initiation Of HERMIONE, A Randomized Trial Of MM-302 In Patients With Advanced HER2-Positive Breast Cancer To Support Application For Accelerated Approval 8/11/2014 7:33:02 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Timing Of Second Quarter 2014 Investor Conference Call 8/4/2014 3:38:56 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents Data From Phase 3 NAPOLI-1 Study At The ESMO 16th World Congress On Gastrointestinal Cancer 6/26/2014 7:39:47 AM
Sanofi (France) (SAN.PA) Throws Cancer Drug Back To Merrimack Pharmaceuticals Inc. (MACK) 6/20/2014 6:57:26 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Oral Presentation Of Additional Data Results In Phase 3 NAPOLI-1 Study At The ESMO 16th World Congress On Gastrointestinal Cancer 6/17/2014 8:50:14 AM
12345678910...